$CERO 4 SEC Filings

Filed On	Filing
21 Apr 2026	Form 4: Francois Eric, Director Granted 1,823,278 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Rolfe Lindsey, Director Granted 690,900 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Laporte Kathleen, Director Granted 690,900 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Pierce Kristen, Chief Development Officer Granted 1,612,099 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Patel Shami, Director Granted 690,900 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Atwood Brian G, Director Granted 1,612,099 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Ehrlich Christopher B, Director Granted 4,530,997 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Byrnes Michael, Director Granted 690,900 Stock Option (Right to Buy)
09 Jan 2026	Form 4: Kucharchuk Andrew Albert, Chief Financial Officer Granted 1,162,099 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Laporte Kathleen, Director Granted 9,326 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Byrnes Michael, Director Granted 9,326 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Rolfe Lindsey, Director Granted 9,326 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Patel Shami, Director Granted 11,693 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Ehrlich Christopher B, Director Granted 61,843 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Atwood Brian G, Director Granted 122,549 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Pierce Kristen, Chief Development Officer Granted 154,841 Stock Option (Right to Buy)
02 Jun 2025	Form 4: Kucharchuk Andrew Albert, Chief Financial Officer Granted 152,500 Stock Option (Right to Buy)
04 Apr 2025	Form 4: Atwood Brian G, Director Received 294,460 shares by exercise or conversion ($29.4) · Acquired 294,460 Pre-Funded Warrant (Option Exercise/Conversion) ($29.4)
06 Mar 2025	Form 4: Laporte Kathleen, Director Granted 17,923 Stock Option (Right to Buy)
06 Mar 2025	Form 4: Rolfe Lindsey, Director Granted 17,923 Stock Option (Right to Buy)

Comments